Deferred Tax Assets, Valuation Allowance of Intellia Therapeutics, Inc. from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Intellia Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • Intellia Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $914,641,000, a 17% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Intellia Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $914,641,000 +$131,430,000 +17% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $783,211,000 +$167,129,000 +27% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q4 2023 $616,082,000 +$161,289,000 +35% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q4 2022 $454,793,000 +$150,012,000 +49% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 $304,781,000 +$163,913,000 +116% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 $140,868,000 +$42,355,000 +43% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 $98,513,000 +$34,467,000 +54% 31 Dec 2019 10-K 26 Feb 2021 2020 FY
Q4 2018 $64,046,000 +$28,674,000 +81% 31 Dec 2018 10-K 27 Feb 2020 2019 FY
Q4 2017 $35,372,000 +$14,823,000 +72% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q4 2016 $20,549,000 +$13,097,000 +176% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q4 2015 $7,452,000 31 Dec 2015 10-K 14 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.